Search results
Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News
Zacks via Yahoo Finance· 3 days agoIn the past six months, shares of MRNA have rallied 108.94%. (See the last biotech stock roundup...
Here's how U.S. health officials are responding to bird flu in humans after second case
CNBC· 2 days agoU.S. health officials are monitoring and preparing to combat bird flu in humans, even as they...
Penn researchers made an avian flu vaccine using a technique that created COVID vaccines
Philly.com· 3 days agoUniversity of Pennsylvania researchers have developed an mRNA vaccine for the H5N1 avian flu drawing...
Sanofi (SNY) Signs Deal for AI-Powered Drug Development
Zacks via Yahoo Finance· 5 days agoWe note that there is a huge potential for AI to accelerate and shape the future of drug...
Dow Jones Today: Stocks Slip as Fed Minutes Spook Investors Ahead of Nvidia Earnings
Investopedia· 4 days agoU.S. stocks slid from record highs on Wednesday after the minutes of the Federal Reserve's May...
Dow Jones Inches Up As Nvidia Rallies On These Calls; Retailer On 64% Run Clears New Entry
Investor's Business Daily· 6 days agoThe Dow Jones was up on the stock market today. AI leader Nvidia got some price target hikes. Li...
Equities Analysts Issue Forecasts for Pfizer Inc.’s Q3 2025 Earnings (NYSE:PFE)
ETF DAILY NEWS· 1 day agoPfizer Inc. (NYSE:PFE – Free Report) – Stock analysts at Zacks Research dropped their Q3 2025 EPS estimates for Pfizer in a research report issued on Wednesday, May 22nd.
Oracle, Moderna, Palantir Technologies And A Big Bank On CNBC’s ‘Final Trades’ - Oracle (NYSE:ORCL)
Benzinga· 4 days agoOn CNBC's "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners named Oracle Corporation...
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
Zacks· 3 days agoFree Report) and Pfizer (PFE Quick QuotePFE - Free Report) to set up a possible vaccine program aimed at preventing the spread of the H5N1 virus, also known as bird flu, in humans. Both these ...
'New era of growth': AstraZeneca sets out bold plans for $80bn revenues by 2030
Evening Standard via Yahoo Finance· 5 days agoThe biggest company on London’s stock market, AstraZeneca, set out bold plans today for what it’s...